Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients
- PMID: 2686547
- PMCID: PMC172742
- DOI: 10.1128/AAC.33.10.1709
Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients
Abstract
We monitored the modifications of oral and intestinal microfloras of 10 allogeneic bone marrow recipients who received randomly either norfloxacin or pefloxacin (400 mg three times a day) as selective decontamination for infection prevention. After 1 week of treatment, in all patients members of the family Enterobacteriaceae were no longer detectable and in all but one pefloxacin-treated patient enterococci were also eliminated in the intestine. The anaerobic flora was not affected, with the exception of Bacteroides spp., markedly reduced after treatment with pefloxacin. In most patients the most striking effect was the increase in staphylococcal counts. These strains were found to be resistant to both quinolones in the study. Less consistent changes were observed in oral flora. No relevant difference could be demonstrated between the two regimens on bacterial counts either in feces or in saliva. This study shows the efficacy of both quinolones in eradicating gram-negative bacilli in the alimentary tract of bone marrow transplant patients; however, the finding of the overgrowth of resistant gram-positive organisms during treatment with these agents deserves further evaluation.
Similar articles
-
Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers.Antimicrob Agents Chemother. 1987 Nov;31(11):1665-8. doi: 10.1128/AAC.31.11.1665. Antimicrob Agents Chemother. 1987. PMID: 3481248 Free PMC article.
-
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.Infection. 1988;16(1):8-12. doi: 10.1007/BF01646921. Infection. 1988. PMID: 3283041 Review.
-
Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group.Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):551-6. doi: 10.1007/BF01967479. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2504598
-
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):564-8. Pathol Biol (Paris). 1985. PMID: 3937128 French.
-
Effect of quinolones on intestinal ecology.Drugs. 1999;58 Suppl 2:65-70. doi: 10.2165/00003495-199958002-00013. Drugs. 1999. PMID: 10553709 Review.
Cited by
-
Colonization resistance.Antimicrob Agents Chemother. 1994 Mar;38(3):409-14. doi: 10.1128/AAC.38.3.409. Antimicrob Agents Chemother. 1994. PMID: 8203832 Free PMC article. Review. No abstract available.
-
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.Antimicrob Agents Chemother. 1994 Apr;38(4):681-7. doi: 10.1128/AAC.38.4.681. Antimicrob Agents Chemother. 1994. PMID: 8031031 Free PMC article.
-
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.Eur J Clin Microbiol Infect Dis. 1993 Jan;12(1):1-8. doi: 10.1007/BF01997049. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8385015 Clinical Trial.
-
Impact of the fluoroquinolones on gastrointestinal flora.Drugs. 1993;45 Suppl 3:125-33. doi: 10.2165/00003495-199300453-00021. Drugs. 1993. PMID: 7689443 Review.
-
Species identification and detection of oxacillin resistance in coagulase-negative Staphylococcus blood isolates from neutropenic patients.Eur J Epidemiol. 1991 Nov;7(6):686-9. doi: 10.1007/BF00218683. Eur J Epidemiol. 1991. PMID: 1783063
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous